[Hypochondriasis and cognitive therapy]

[Hypochondriasis and cognitive therapy] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Hypochondriasis and cognitive therapy] Abstract Text:

BACKGROUND: Hypochondriasis is an annoying disorder. Diagnostic criteria for primary and secondary hypochondriasis as well as comorbidity are explained. MATERIAL AND METHODS: Some studies of prevalence, aetiology and treatment are reviewed. Special emphasis is given to the cognitive model. RESULTS AND INTERPRETATION: The prevalence of primary hypochondriasis in population studies is around 1%, while the prevalence in medical outpatient clinics is 3-4.5%. Several controlled, clinical studies have found positive effect of cognitive-behavioural therapy. Excessive health anxiety that is secondary to depression disappears when the primary disorder is treated. Controlled clinical trials of medication is lacking. Traditionally, hypochondriasis has been considered a difficult diagnosis to present to the patient and hard to treat. Research has increased our knowledge and understanding of the disease, and structured treatment protocols have led to a well founded optimism concerning prognosis. Central themes in the consultations are the question of life and death, interpretation of subjective somatic symptoms and the ability to make decisions when still in doubt.

[Hypochondriasis and cognitive therapy] Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Hypochondriasis and cognitive therapy] Journal Published:

PUBLICATION TYPE: Review

Journal: Tidsskrift for den Norske lægeforening : tidsskrif

VOLUME: 122

Page Numbers: 1126-9

Journal Abbreviation: Tidsskr. Nor. Laegeforen.

ISSN: 0029-2001

DAY: 30

MONTH: Apr

YEAR: 2002

[Hypochondriasis and cognitive therapy] Information

Number of References: 33

LANGUAGE: nor

NlmUniqueID: 413423

[Hypochondriasis and cognitive therapy] Keywords Mesh Terms:

KEYWORDS: Psychophysiologic Disorders

MESH TERMS: therapy

Chemical & Substance for Abstract: [Hypochondriasis and cognitive therapy] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Hypochondriasis and cognitive therapy]

AFFILIATION: Institutt for indremedisin Diakonissehjemmets sykehus Haraldsplass Universitetet i Bergen 5009 Bergen. ingvard.wilhelmsen@med.uib.no

Country: Norway

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Tidsskr Nor Laegeforen

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Hypochondriasis and cognitive therapy Related Publications

• A monitor for neutron flux measurements up to 20 MeV.
• Age at first intoxication and alcohol use disorders in Southwest California Indians.
• Anaerobic infections in clinical medicine. A microbiological and clinical introduction.
• Association Between Single Nucleotide Polymorphisms in the Cannabinoid Receptor Gene (CNR1) and Impulsivity in Southwest California Indians.
• Association between fibrinogen and other risk factors for cardiovascular disease in men and women. Results from the Göteborg MONICA survey 1985.
• Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians.
• Beta-blockers and plasma triglycerides.
• Closing volume in 50- and 60- year old men: (a preliminary report).
• Externalizing disorders in American Indians: comorbidity and a genome wide linkage analysis.
• Genomic screen for loci associated with alcohol dependence in Mission Indians.
• Genomic screen for substance dependence and body mass index in southwest California Indians.
• Impediments to the control of hypertension. Hypertension Management Audit Group.
• Nitrogen closing volume-test in 50- and 60- year-old men.
• Normative data for commercial pineapple juice from concentrate.
• Postoperative pain.
• Prevalence of primary and secondary hypertension: studies in a random population sample.
• Quality of life and Helicobacter pylori eradication.
• Quality of life in upper gastrointestinal disorders.
• Rapidly progressive autosomal dominant Parkinsonism and dementia with Pallido-Ponto-Nigral Gegeneration (PPND) and Disinhibition-Dementia-Parkinsonism-Amyotrophy Complex (DDPAC) are clinically distinct conditions that are both linked to 17q21-22.
• Synergistic effects of risk factors.
• [Cancer of the rectum as labor complication.]
• [Disease anxiety among medical students and law students]
• [Hypochondriasis and cognitive therapy]
• [IRON CONTENT IN RED WINE ETC.]
• [Interferons. Biological principal and practical application]
• [Psychomotor physical therapy--patients' starting point and their evaluation of the therapeutic results]
• [Psychotherapeutic counselling via telecommunication networks]
• [Rupture of the uterus; case report.]